Methodology schema utilized in this analyze for predicting likely antileishmanial compounds. 3 modelling… , et al CDK12 inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA wild-type and mutated types of triple-damaging breast most cancers The location is secure. T